Shu‐Qiang Weng

机构：Fudan University, Zhongshan Hospital · ORCID：0000-0001-7331-3874

发表论文 41 篇 · 总被引 1345 次 · h-index 19

代表论文

• OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism (2019 · Journal of Hepatology · 被引 191)
• Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages (2021 · Journal of Translational Medicine · 被引 58)
• microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit (2020 · Oncogene · 被引 47)
• Bismuth‐Based Mesoporous Nanoball Carrying Sorafenib for Computed Tomography Imaging and Synergetic Chemoradiotherapy of Hepatocellular Carcinoma (2020 · Advanced Healthcare Materials · 被引 26)
• Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma (2022 · ACS Applied Materials & Interfaces · 被引 23)
• Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma (2020 · Annals of Surgical Oncology · 被引 22)